On March 12, 2026, the Food Standards Agency (FSA) and Food Standards Scotland (FSS) published updated guidance on the authorisation process for novel foods in Great Britain, clarifying regulatory requirements for companies seeking to place novel food products on the market. The update applies to businesses operating across England, Scotland, and Wales and outlines the full procedural pathway from pre-application to final decision-making.
アップデートの詳細
The revised guidance provides a structured overview of the pre-application process, including how applicants must determine the correct regulatory regime, identify the appropriate product classification, and prepare a comprehensive evidence dossier. Applications must be submitted through the regulated products portal, followed by validation checks, 安全性評価 conducted by FSA/FSS and independent experts, a public consultation phase, そして final ministerial decisions.
The guidance emphasizes that applicants must first confirm whether their product qualifies under the novel foods regime, as certain categories such as genetically modified organisms (GMOs), 添加物、 そして enzymes are explicitly excluded from this pathway. It further explains that evidence requirements vary depending on product class, 、 と EFSA technical guidance remaining relevant for dossier preparation.
The update also highlights that incomplete applications will not be accepted, reinforcing stricter validation checks prior to assessment. Companies may request confidentiality and data protection measures for commercially sensitive information included in their submissions. Once validated, applications proceed through public consultation on draft recommendations before a final ministerial decision is made in each nation
なぜそれが重要なのか
This update introduces greater 規制の明確さ by defining pre-application expectations and procedural steps, supporting デジタルアライメント through the regulated products portal, and improving process efficiency with clearer validation requirements. The inclusion of a mandatory public consultation phase enhances transparency while maintaining a neutral compliance burden 業界関係者向け。.
誰に関係があるか
このアップデートは、 regulatory affairs teams, quality assurance professionals, R&D teams, and legal or compliance functions involved in the development, assessment, and commercialization of novel food products in Great Britain.
次のステップ
Organizations should review the updated FSA/FSS guidance to confirm product eligibility under the novel foods framework and ensure that their evidence dossiers align with current technical standards, including those referenced from EFSA. Teams should also prepare data protection considerations when handling commercially sensitive information and coordinate internally across regulatory, R&D, and legal functions before submitting applications via the regulated products portal.
As regulatory processes become more structured and data-driven, leveraging advanced solutions can help streamline compliance efforts. RegASK は、消費財やライフサイエンスなど、規制の厳しい分野のグローバル組織が複雑な規制環境を積極的に乗り越えられるよう支援する、業界をリードするエージェント型AI規制インテリジェンスおよびワークフローオーケストレーションプラットフォームです。高度なエージェント型AIと専門家の知見を組み合わせることで、, RegASK タイムリーで予測に基づいた実用的な洞察とエンドツーエンドの自動化を提供し、コンプライアンスプロセスを合理化し、リスクを軽減し、160か国以上で市場アクセスを加速します。. もっと詳しく知る または 今すぐデモを予約してください。
よくある質問
What is the novel foods 承認 process in Great Britain?
It is a regulatory pathway requiring companies to 提出する a validated application, including a comprehensive evidence dossier, followed by safety assessments, public consultation, and ministerial approval.
Which products are excluded from the novel foods regime?
Products classified as genetically modified organisms (GMOs), additives, enzymes, or other specified categories are not eligible under this pathway.
What are the key requirements for 提出 a novel foods application?
Applicants must determine the correct regulatory regime, select the appropriate product class, prepare a complete evidence dossier aligned with FSA/FSS and EFSA guidance, and 提出する via the regulated products portal.
どうすれば RegASK support novel foods regulatory compliance?
RegASK 組織を支援する モニター evolving regulatory requirements, prepare compliant dossiers, and streamline submission workflows through AI-driven insights and end-to-end regulatory process automation.
